Antipsychotic‐Treated Schizophrenia Patients Develop Inflammatory and Oxidative Responses Independently From Obesity: However, Metabolic Disturbances Arise From Schizophrenia‐Related Obesity
Our results suggest that inflammatory responses and oxidative stress develop independently from obesity in antipsychotic-treated schizophrenia patients. However, schizophrenia-induced obesity causes metabolic disturbances; thereby, obese schizophrenia patients are more liable to cardiovascular events and progress of metabolic syndrome than non-obese patients.
Authors
- Salih Saygın Eker (ORCID: https://orcid.org/0000-0003-4629-8669)
- Emre Sarandöl (ORCID: https://orcid.org/0000-0002-2593-7196)
- Mesut Şener (ORCID: https://orcid.org/0009-0008-8209-5942)
- Aslı Sarandöl (ORCID: https://orcid.org/0000-0002-1092-8254)
- Esma Sürmen-Gür (ORCID: https://orcid.org/0000-0001-7377-9682)
Institutions
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
Publication Details
- Journal
- Human Psychopharmacology Clinical and Experimental
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/hup.2913
- Citations
- 3
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Bursa Uludağ Üniversitesi